Department of Ultrasound, The Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Tianhe District, Guangzhou, 510630, Guangdong, People's Republic of China.
Abdom Radiol (NY). 2022 Aug;47(8):2928-2936. doi: 10.1007/s00261-022-03558-6. Epub 2022 Jun 7.
This retrospective study aimed to compare the performance of contrast-enhanced ultrasound (CEUS) and magnetic resonance imaging (MRI) in staging surgically treated early-stage cervical cancer.
Patients with surgically treated cervical carcinoma confirmed by post-operative pathological findings were included between December 2016 and December 2018. All included patients underwent both CEUS and MRI examinations before the surgery. Post-operative pathology was used as the gold standard. The κ values were calculated to assess the agreements of CEUS and MRI in staging cervical carcinoma in comparison with post-operative pathology.
Complete data were available for 39 patients. CEUS showed great inter-observer reproducibility in tumor measurement [Intra-class Correlation Coefficient (ICC) 0.831] and moderate inter-observer reproducibility in the evaluation of vaginal infiltration and parametrial invasion (Cohen's κ 0.692 and 0.624). Tumor size was comparable as measured by CEUS and MRI (ICC 0.769). Both CEUS and MRI presented good concordance with post-operative pathology in staging cervical cancer (weighted κ 0.732 and 0.761).
CEUS was comparable to MRI in staging surgically treated cervical cancer and might be considered in the pre-treatment work-up for cervical cancer.
本回顾性研究旨在比较对比增强超声(CEUS)和磁共振成像(MRI)在手术治疗早期宫颈癌分期中的性能。
纳入 2016 年 12 月至 2018 年 12 月期间经术后病理证实为手术治疗宫颈癌的患者。所有纳入的患者均在术前接受 CEUS 和 MRI 检查。术后病理为金标准。计算κ 值以评估 CEUS 和 MRI 在与术后病理比较的宫颈癌分期中的一致性。
39 例患者的完整数据可用。CEUS 在肿瘤测量方面具有很好的观察者间可重复性[组内相关系数(ICC)0.831],在评估阴道浸润和宫旁侵犯方面具有中等的观察者间可重复性(Cohen's κ 0.692 和 0.624)。CEUS 和 MRI 测量的肿瘤大小相当(ICC 0.769)。CEUS 和 MRI 在宫颈癌分期方面与术后病理具有良好的一致性(加权κ值分别为 0.732 和 0.761)。
CEUS 在手术治疗宫颈癌的分期中与 MRI 相当,可在宫颈癌的术前评估中考虑使用。